These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23372960)
1. A case of malignant peritoneal mesothelioma revealed with limitation of PET-CT in the diagnosis of thoracic metastasis. Saraya T; Yokoyama T; Ishii H; Tanaka Y; Tsujimoto N; Ogawa Y; Sohara E; Nakajima A; Inui T; Sayuki H; Fujiwara M; Oka T; Kawachi R; Goya T; Takizawa H; Goto H J Thorac Dis; 2013 Feb; 5(1):E11-6. PubMed ID: 23372960 [TBL] [Abstract][Full Text] [Related]
2. A Case of Localized Malignant Peritoneal Mesothelioma Evaluated by 18F-FDG PET/CT. Xu T; Hu J; Zhang X; Cao J; Chen Y Clin Nucl Med; 2020 Nov; 45(11):890-891. PubMed ID: 32604114 [TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Cao Q; Lu M; Heath J; Hausner PF; Alexander HR; Dilsizian V; Chen W Clin Nucl Med; 2012 May; 37(5):492-4. PubMed ID: 22475902 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889 [TBL] [Abstract][Full Text] [Related]
5. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? Sharif S; Zahid I; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493 [TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Gerbaudo VH; Mamede M; Trotman-Dickenson B; Hatabu H; Sugarbaker DJ Eur J Nucl Med Mol Imaging; 2011 May; 38(5):810-21. PubMed ID: 21210110 [TBL] [Abstract][Full Text] [Related]
7. A Case of Localized Malignant Peritoneal Mesothelioma With Lung Cancer Detected by 18F-FDG PET/CT. Kobayashi Shimizu S; Okamura T; Koyama K; Seura H; Nishida N Clin Nucl Med; 2020 Oct; 45(10):795-797. PubMed ID: 32558713 [TBL] [Abstract][Full Text] [Related]
9. Is FDG-PET/CT useful for managing malignant pleural mesothelioma? Otsuka H; Terazawa K; Morita N; Otomi Y; Yamashita K; Nishitani H J Med Invest; 2009 Feb; 56(1-2):16-20. PubMed ID: 19262009 [TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT. Huang YC; Tu DG; Wu JD; Lee MY Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799 [TBL] [Abstract][Full Text] [Related]
11. Malignant Peritoneal Mesothelioma Masquerades as Peritoneal Metastasis on (18)F-FDG PET/CT Scans; a Rare Diagnosis that Should Not Be Missed. Claimon A; Bang JI; Cheon GJ; Kim EE; Lee DS Nucl Med Mol Imaging; 2015 Dec; 49(4):325-8. PubMed ID: 26550054 [TBL] [Abstract][Full Text] [Related]
12. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971 [TBL] [Abstract][Full Text] [Related]
16. Pleuroperitoneal Mesothelioma: A Rare Entity on 18F-FDG PET/CT. Sahoo MK; Mukherjee A; Girish ; Parida K; Agarwal KK; Bal C; Tripathi M; Das CJ; Shamim SA Indian J Nucl Med; 2017; 32(1):75-76. PubMed ID: 28242997 [TBL] [Abstract][Full Text] [Related]
17. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Mahmood S; Martinez de Llano SR Clin Nucl Med; 2008 Jul; 33(7):510-2. PubMed ID: 18580246 [TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results. Lococo F; Rena O; Torricelli F; Filice A; Rapicetta C; Boldorini R; Paci M; Versari A Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):593-596. PubMed ID: 32003806 [TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
20. What is the best way to diagnose and stage malignant pleural mesothelioma? Zahid I; Sharif S; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]